Université de Strasbourg;Institut National de la Santé et de la Recherche Médicale
发明人:
申请号：
EP16306539.4
公开号：
EP3323422A1
申请日:
2016.11.22
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to a cateslytin peptide having an amino acid sequence consisting or consisting essentially in the sequence of SEQ ID NO: 1, wherein at least 80%, preferably at least 90%, of the amino acids residues of said cateslytin are D-configured. The invention also relates to the use of said cateslytin peptide as a drug, especially in the treatment of an infection in a patient in needs thereof.
